EAN 2025: Early Add-On Therapy Shows Benefit in Myasthenia Gravis
Dr. Menekse Öztürk, a Neurology Resident at BG University Hospital Bergmannsheil, Germany, presents preliminary data from a multicentre real-world cohort study on treatment timing in generalised myasthenia gravis. Patients who received early add-on therapy, within 24 months of diagnosis, showed trends toward better clinical outcomes, improved quality of life, and more efficient steroid tapering.
Få tilgang
Hvis du er lege, sykepleier eller annen helsepersonell, kan du få tilgang til hele artikkelen ved å opprette en profil på BestPractice Nordic.
- Få tilgang
- Hvis du allerede har en profil: Logg in
